Cancer Risk
12
11
12
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (12)
Norris ORIEN Total Cancer Care
Clinical Biospecimen Collection
Cancer PRevention Through Enhanced EnvironMenT
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Morehouse Total Cancer Care Protocol